Sichuan Goldstone Asia Pharmaceutical Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 376.878 million compared to CNY 208.017 million a year ago. Operating income was CNY 91.772 million compared to CNY 25.170 million a year ago. Net income was CNY 78.903 million compared to CNY 19.698 million a year ago. Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.05 a year ago.